197 related articles for article (PubMed ID: 15466129)
41. Acute dyskinesia on starting methylphenidate after risperidone withdrawal.
Hollis CP; Thompson A
Pediatr Neurol; 2007 Oct; 37(4):287-8. PubMed ID: 17903675
[TBL] [Abstract][Full Text] [Related]
42. Efficacy and safety of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, double-blind, parallel group, dose-escalation study.
Adler LA; Zimmerman B; Starr HL; Silber S; Palumbo J; Orman C; Spencer T
J Clin Psychopharmacol; 2009 Jun; 29(3):239-47. PubMed ID: 19440077
[TBL] [Abstract][Full Text] [Related]
43. Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity.
Research Units on Pediatric Psychopharmacology Autism Network
Arch Gen Psychiatry; 2005 Nov; 62(11):1266-74. PubMed ID: 16275814
[TBL] [Abstract][Full Text] [Related]
44. Methylphenidate-associated enuresis in attention deficit hyperactivity disorder.
Ghanizadeh A
J Pediatr Urol; 2008 Aug; 4(4):306-7. PubMed ID: 18644535
[TBL] [Abstract][Full Text] [Related]
45. An ADHD 6-year-old child ultrarapid metabolizer for CYP2D6.
Bonnet-Brilhault F; Broly F; Blanc R; Furet Y; Barthélémy C; Paintaud G
J Clin Psychopharmacol; 2006 Aug; 26(4):442-4. PubMed ID: 16855474
[No Abstract] [Full Text] [Related]
46. Real impairments, real treatments.
Kramer PD
Am J Bioeth; 2005; 5(3):62-3; discussion W10-2. PubMed ID: 16006347
[No Abstract] [Full Text] [Related]
47. Transdermal methylphenidate, behavioral, and combined treatment for children with ADHD.
Pelham WE; Burrows-Maclean L; Gnagy EM; Fabiano GA; Coles EK; Tresco KE; Chacko A; Wymbs BT; Wienke AL; Walker KS; Hoffman MT
Exp Clin Psychopharmacol; 2005 May; 13(2):111-26. PubMed ID: 15943544
[TBL] [Abstract][Full Text] [Related]
48. ADHD, values, and the self.
Litton P
Am J Bioeth; 2005; 5(3):65-7; discussion W10-2. PubMed ID: 16006360
[No Abstract] [Full Text] [Related]
49. [Is Ritalin prescribed insufficiently to hyperactive children in Nordland?].
Neraal T
Tidsskr Nor Laegeforen; 2001 May; 121(14):1735-6. PubMed ID: 11446022
[No Abstract] [Full Text] [Related]
50. From the Editor-in-Chief's Desk.
Koplewicz HS
J Child Adolesc Psychopharmacol; 2019 Apr; 29(3):167. PubMed ID: 30946620
[No Abstract] [Full Text] [Related]
51. Aptensio XR--another long-acting methylphenidate.
Med Lett Drugs Ther; 2015 Jul; 57(1473):101-3. PubMed ID: 26204039
[No Abstract] [Full Text] [Related]
52. A new long-acting methylphenidate (Concerta).
Med Lett Drugs Ther; 2000 Sep; 42(1086):80-1. PubMed ID: 10980811
[No Abstract] [Full Text] [Related]
53. Another long-acting methylphenidate (Metadate CD).
Med Lett Drugs Ther; 2001 Oct; 43(1114):83-4. PubMed ID: 11581582
[No Abstract] [Full Text] [Related]
54. Beyond "real boys" and back to parental obligations.
Hughes J
Am J Bioeth; 2005; 5(3):61-2; discussion W10-2. PubMed ID: 16006373
[No Abstract] [Full Text] [Related]
55. Impact of withdrawal of Ritalin LA in the Western Cape.
Donker Fv; Riordan G; Wilmshurst J
S Afr Med J; 2008 Aug; 98(8):570. PubMed ID: 18928026
[No Abstract] [Full Text] [Related]
56. Beyond creativity: ADHD drug therapy as a moral damper on a child's future success.
Krautkramer CJ
Am J Bioeth; 2005; 5(3):52-3. PubMed ID: 16006377
[No Abstract] [Full Text] [Related]
57. [Comment on the European guidelines for use of delayed action drugs for treatment of hyperkinetic disorders].
Banaschewski T; Döpfner M; Rothenberger A; Steinhausen H-
Z Kinder Jugendpsychiatr Psychother; 2008 Mar; 36(2):77-9. PubMed ID: 18622937
[No Abstract] [Full Text] [Related]
58. Methylphenidate.
Nicolle FI
Am Fam Physician; 1983 Nov; 28(5):27-8. PubMed ID: 6637755
[No Abstract] [Full Text] [Related]
59. 'Real' ethics for 'real' boys: context and narrative in bioethics.
Hoffmaster B
Am J Bioeth; 2005; 5(3):50-1; discussion W10-2. PubMed ID: 16006351
[No Abstract] [Full Text] [Related]
60. Drugs for ADHD.
Med Lett Drugs Ther; 2015 Mar; 57(1464):37-40. PubMed ID: 25758544
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
